Logo-ipp

Epidemiology and Prevention

1. Acute respiratory distress syndrome in COVID-19
Nahid Dadashzadeh, Saman Farshid ORCID, Rohollah Valizadeh ORCID, Mohammad Nanbakhsh, Mohsen Mohammad Rahimi* ORCID
Immunopathol Persa. 2020;6(2): e16. doi: 10.34172/ipp.2020.16
Scopus ID: 85085255542    
Article
PDF
XML
Cited By:
19
14
Epidemiology and Prevention

2. Collapsing glomerulopathy following COVID-19 infection; possible relationship with APOL1 kidney risk alleles in African-Americans
Muhammed Mubarak ORCID, Ramin Tolouian ORCID, Aiyoub Pezeshgi*
Immunopathol Persa. 2020;6(2): e18. doi: 10.34172/ipp.2020.18
Scopus ID: 85087871237    
Article
PDF
XML
Cited By:
8
5
Mini-Review

3. The footprint of androgen sensitive serine protease (TMPRSS2) in gender mortality with COVID-19
Sepideh Zununi Vahed ORCID, Shahram Ghiyasvand ORCID, Ramin Tolouian ORCID, Hamid Noshad ORCID, Audrey Tolouian ORCID, Mohammadali Mohajel Shoja ORCID, Mohammadreza Ardalan* ORCID
Immunopathol Persa. 2020;6(2): e27. doi: 10.34172/ipp.2020.27
Scopus ID: 85096072083    
Article
PDF
XML
Cited By:
10
7
Review

4. Sphingosine 1 phosphate agonists (SPI); a potential agent to prevent acute lung injury in COVID-19
Sepideh Zununi Vahed ORCID, Shahram Ghiyasvand, Seyed Mahdi Hosseiniyan Khatibi ORCID, Bhargav Patel ORCID, Mohammadali Mohajel Shoja, Ramin Tolouian ORCID, Mohammadreza Ardalan ORCID
Immunopathol Persa. 2021;7(1): e03. doi: 10.34172/ipp.2021.03
Scopus ID: 85105041326    
Article
PDF
XML
Cited By:
4
3
Epidemiology and Prevention

5. Kinin–kallikrein system; a possible pathway responsible for COVID-19
Keivan Mohammadi*, Aliye Tabatabaee, Mojtaba Akbari
Immunopathol Persa. 2021;7(1): e11. doi: 10.34172/ipp.2021.11
Scopus ID: 85105033693    
Article
PDF
XML
Cited By:
0
0
Editorial

6. Controversy with bromhexine in COVID-19; where we stand
Ramin Tolouian* ORCID, Zuber D. Mulla ORCID
Immunopathol Persa. 2021;7(2): e12. doi: 10.34172/ipp.2021.12
Scopus ID: 85102581659    
Article
PDF
XML
Cited By:
3
3
Original

7. Investigation of hematological parameters related to the severity of COVID-19 disease in Mashhad, Iran
Mohsen Seddigh-Shamsi ORCID, Shima Nabavi Mahali ORCID, Mahnaz Mozdourian ORCID, Abolghasem Allahyari ORCID, Neda Saeedian ORCID, Maryam Emadzade, Farnoosh Ebrahimzadeh ORCID, Zahra Javidarabshahi ORCID, Shohre Khatami ORCID, Mina Akbari Rad ORCID, Sahar Ravanshad ORCID, Maryam Naghavi ORCID, Zahra Mozaheb ORCID, Mohammad Moeini Nodeh ORCID, Hossein Rahimi ORCID, Alireza Bary, Mostafa Kamandi ORCID, Sajad Ataei Azimi ORCID, Mohammad Ali Yaghoubi ORCID, Zahra Rezaei Borojerdi* ORCID
Immunopathol Persa. 2021;7(2): e19. doi: 10.34172/ipp.2021.19
Scopus ID: 85112525816    
Article
PDF
XML
Cited By:
2
3
Case Series

8. The effect of hemoperfusion on the recovery of COVID-19 in hospitalized patients; case series and review study
Sepideh Hajian ORCID, Nafiseh Rastgoo* ORCID
Immunopathol Persa. 2021;7(2): e13. doi: 10.34172/ipp.2021.13
Scopus ID: 85112495186    
Article
PDF
XML
Cited By:
1
1
Epidemiology and Prevention

9. Feasibility of pulmonary physiotherapy in pediatric patients with COVID-19
Seyed Mohammad Amin Hashemipour ORCID, Nasrin Ghiasi ORCID, Parisa Arzani* ORCID, Rohollah Valizadeh ORCID
Immunopathol Persa. 2021;7(2): e24. doi: 10.34172/ipp.2021.24
Scopus ID: 85112519230    
Article
PDF
XML
Cited By:
1
1
Original

10. Clinical course and outcome in diabetic patients with COVID-19

Zahra Davoudi ORCID, Ilad Alavi Darazam ORCID, Farnaz Saberian ORCID, Sina Homaee ORCID, Shervin Shokouhi ORCID, Minoosh Shabani ORCID, Latif Gachkar* ORCID
Immunopathol Persa. 2021;7(2): e23. doi: 10.34172/ipp.2021.23
Scopus ID: 85112511735    
Article
PDF
XML
Cited By:
0
1
Review

11. High risk individuals in COVID-19 pandemic; an updated review
Rojin Chegini ORCID, Alireza Bolurian ORCID, Zahra Mojtahedi ORCID, Masoud Hafizi* ORCID
Immunopathol Persa. 2021;7(2): e25. doi: 10.34172/ipp.2021.25
Scopus ID: 85102568029    
Article
PDF
XML
Cited By:
2
1

Review

12. Conjunctivitis and other ocular manifestation following COVID-19; updated information about transmission of COVID-19 by eye
Mohsen Mirshamsi ORCID, Nasrin Ghiasi ORCID, Sharareh Heidari, Parisa Hosseinpour ORCID, Babak Hassanlouei ORCID, Seyed Mohammad Amin Hashemipour ORCID, Naser Samadi Aidenloo* ORCID, Rohollah Valizadeh ORCID
Immunopathol Persa. 2021;7(2): e28. doi: 10.34172/ipp.2021.28
Scopus ID: 85112506410    
Article
PDF
XML
Cited By:
4
3
Original

13. The severity of symptoms and outcomes of patients admitted with rheumatic diseases and COVID-19; a prospective cohort study in Iran
Mansour Salesi ORCID, Ramin Sami ORCID, Somayeh Haji Ahmadi ORCID, Nilufar Khademi ORCID, Mehrnegar Dehghan ORCID, Soheila Jalali ORCID, Marjan Mansourian ORCID, Huriyeh Hashemi* ORCID
Immunopathol Persa. 2021;7(2): e34. doi: 10.34172/ipp.2021.34
Scopus ID: 85112513490    
Article
PDF
XML
Cited By:
1
1
Original

14. Potential factors related to post-COVID-19 persistent symptoms; Khorshid COVID cohort study
Ramin Sami ORCID, Zahra Khani Khoozani ORCID, Marjan Mansourian ORCID, Zohre Naderi ORCID, Mehdi Karami ORCID, Mina Nickpour ORCID, Arash Toghyani ORCID, Ali Gharavinia ORCID, Nastaran Sadat Hosseini ORCID, Mehrnegar Dehghan ORCID, Midia Babahajiani ORCID, Nafiseh Shokri-Mashhadi* ORCID
Immunopathol Persa. 2023;9(2): 22223. doi: 10.34172/ipp.2022.22223
Scopus ID: 85164611766    
Article
PDF
XML
Cited By:
0
0

Original

15. The effect of vitamin E and vitamin C in patients with COVID-19 pneumonia; a randomized controlled clinical trial
Atousa Hakamifard ORCID, Rasool Soltani ORCID, Ahmadreza Maghsoudi* ORCID, Ali Rismanbaf, Marzieh Aalinezhad, Mohammad Javad Tarrahi, Sanaz Mashayekhbakhsh, Kian Dolatshahi
Immunopathol Persa. 2022;8(1): e8. doi: 10.34172/ipp.2022.08
Scopus ID: 85129531033    
Article
PDF
XML
Cited By:
12

Review

16. Accuracy of chest computed tomography and reverse transcription polymerase chain reaction in diagnosis of 2019 novel coronavirus disease; a systematic review and meta-analysis
Kamyar Shokraee ORCID, Hossein Mahdavi ORCID, Parsa Panahi ORCID, Farnoosh Seirafianpour ORCID, Amir Mohammad Jahromizadeh ORCID, Rozhin Tofighi ORCID, Ali Amirkafi ORCID, Delaram Moosavi ORCID, Soheila Mahdavynia ORCID, Samira Vaziri ORCID, Hojat Dehghanbanadaki ORCID, Hossein Aazami ORCID, Ali Kabir* ORCID
Immunopathol Persa. 2021;7(2): e36. doi: 10.34172/ipp.2021.36
Scopus ID: 85112510011    
Article
PDF
XML
Cited By:
1
1
Original

17. Prophylactic effects of hydroxychloroquine on the incidence of COVID-19 in patients with rheumatic arthritis: an observational cohort study

Zohre Naderi ORCID, Bahar Sadeghi, Ziba Farajzadegan ORCID, Ramin Sami ORCID, Mansour Salesi* ORCID, Vahid Mansouri* ORCID, Babak Amra ORCID
Immunopathol Persa. 2021;7(2): e29. doi: 10.34172/ipp.2021.29
Scopus ID: 85112543737    
Article
PDF
XML
Cited By:
0
0
Case Report

18. Acute progressive arterial thrombosis after coronary artery bypass graft in a COVID-19 patient
Mahmoud Beheshti Monfared ORCID, Hamid Ghaderi ORCID, Zahra Ansari Aval* ORCID, Seyedeh Adeleh Mirjafari ORCID
Immunopathol Persa. 2022;8(1): e5. doi: 10.34172/ipp.2022.05
Scopus ID: 85119207157    
Article
PDF
XML
Cited By:
0
0

Review

19. Resveratrol; an inflammasome inhibitor and a potential therapy for severe cases of COVID-19
Mohammad-Reza Mahmoudian-Sani ORCID, Ali Saeedi Boroujeni ORCID, Ali Khodadadi ORCID, Sheyda Houshmandfar ORCID, Sima Tahmaseby Gandomkari ORCID, Arash Alghasi* ORCID
Immunopathol Persa. 2022;8(1): e9. doi: 10.34172/ipp.2022.09
Scopus ID: 85119266476    
Article
PDF
XML
Cited By:
2
3

Review

20. Efficacy and side effects of Sputnik V, Sinopharm and AstraZeneca vaccines to stop COVID-19; a review and discussion

Nasrin Ghiasi ORCID, Rohollah Valizadeh ORCID, Mohammad Arabsorkhi ORCID, Tahere Sadat Hoseyni, Korosh Esfandiari, Tella Sadighpour* ORCID, Hamid Reza Jahantigh
Immunopathol Persa. 2021;7(2): e31. doi: 10.34172/ipp.2021.31
Scopus ID: 85112552247    
Article
PDF
XML
Cited By:
36
45
Review

21. Gut microbiota in COVID-19 treatment

Tella Sadighpour* ORCID, Audrey Tolouian ORCID
Immunopathol Persa. 2021;7(2): e30. doi: 10.34172/ipp.2021.30
Scopus ID: 85112544125    
Article
PDF
XML
Cited By:
0
0
Review

22. A systematic review and meta-analysis on the association between lymphocyte subsets and the severity of COVID-19
Hojat Dehghanbanadaki ORCID, Hossein Aazami ORCID, Mahya Shabani ORCID, Dorsa Amighi, Farhad Seif ORCID, Ali Zare Dehnavi ORCID, Abdolkarim Hajighadery ORCID, Mohammad-Mehdi Mehrabi Nejad ORCID, Mohammad Ghafouri ORCID, Nima Hajizadeh ORCID, Fateme Abedin ORCID, Zahra Hajizadeh ORCID, Mehrdad Heravi ORCID, Parsa Panahi ORCID, Ali Kabir* ORCID
Immunopathol Persa. 2022;8(2): e29303. doi: 10.34172/ipp.2022.29303
Scopus ID: 85133629380    
Article
PDF
XML
Cited By:
1
0

Clinical Trial

23. A randomized clinical trial study on the efficacy and safety of adalimumab and methylprednisolone pulse therapy in the treatment of COVID-19 patients with acute respiratory distress syndrome
Omid Yazdani ORCID, Ramin Hamidi Farahani ORCID, Reza Mosaed ORCID, Amir Nezami Asl, Ebrahim Hazrati* ORCID
Immunopathol Persa. 2023;9(2): 30322. doi: 10.34172/ipp.2022.30322
Scopus ID: 85164622468    
Article
PDF
XML
Cited By:
0
0

Clinical Trial

24. The combined effect of Algomed and a quadruple herbal brew of Iranian traditional medicine on the severity and outcome of COVID-19; a randomized controlled clinical trial recruiting inpatients
Rahimeh Eskandarian ORCID, Bahador Bagheri ORCID, Mehrdad Zahmatkesh ORCID, Farhad Malek ORCID, Mahboubeh Darban ORCID, Mohammad Memarian ORCID, Ali Gohari ORCID, Mohammad Amir Sarabi ORCID, Majid Mirmohammadkhani* ORCID
Immunopathol Persa. 2023;9(2): 31355. doi: 10.34172/ipp.2022.31355
Scopus ID: 85164609638    
Article
PDF
XML
Cited By:
0
1

Original

25. Clinical, radiological outcomes and pulmonary function tests in patients recovered from COVID-19 in a three-month follow-up

Hanieh Raji ORCID, Seyed Hamid Borsi ORCID, Zahra Mehraban ORCID, Sahar Azizi Moghadam* ORCID
Immunopathol Persa. 2024;10(1): e31362. doi: 10.34172/ipp.2023.31362
Article
PDF
XML
Cited By:
0
Epidemiology and Prevention

26. Could inadvertent intravenous injection of COVID-19 vaccines cause severe adverse events?
Zohreh Tajabadi ORCID, Seyed Amir Ahmad Safavi-Naini ORCID, Bharat Kwatra ORCID, Ali Safavi-Naini* ORCID
Immunopathol Persa. 2022;8(2): e31392. doi: 10.34172/ipp.2022.31392
Scopus ID: 85133699384    
Article
PDF
XML
Cited By:
0
0

Review

27. The dilemma of COVID-19 diagnosis in pregnancy
Wassan Nori* ORCID, Roaa Mokram Hamed ORCID, Wisam Akram ORCID, Maha Chasib Munshid
Immunopathol Persa. 2023;9(2): 32416. doi: 10.34172/ipp.2022.32416
Scopus ID: 85164614129    
Article
PDF
XML
Cited By:
0
0
Review

28. Omicron variant of COVID-19: A focused review of biologic, clinical, and epidemiological changes
Hossein Majlesi ORCID, Saba Shahsavan ORCID, Yeganeh Farsi ORCID, Atena Tamimi ORCID, Saba Ilkhani ORCID, Zohreh Tajabadi ORCID, Alvand Naserghandi ORCID, Niloofar Fakour ORCID, Mohammad Javad Nasiri ORCID, Ehsan Nazemallhoseini-Mojarad ORCID, Seyed Amir Ahmad Safavi-Naini* ORCID
Immunopathol Persa. 2023;9(1): e34449. doi: 10.34172/ipp.2022.34449
Scopus ID: 85145943378    
Article
PDF
XML
Cited By:
1
0
Original Article

29. Clinical signs, symptoms, and severity of COVID-19 in patients with rheumatic diseases during the COVID-19 epidemic

Mansour Salesi, Maryam Sedarat* ORCID
Immunopathol Persa. 2024;10(1): e40568. doi: 10.34172/ipp.2023.40568
Article
PDF
XML
Cited By: